The Legal, Regulatory, and Compliance Event for Safe and Responsible Innovation in the Biopharma and Medical Device/Diagnostic Industries.
Join us on February 20–21, 2025, for essential insights into navigating AI's legal and regulatory landscape in life sciences. Discover how AI is accelerating drug discovery, optimizing clinical trials, and enhancing disease diagnosis to bridge innovation with real-world healthcare.
Charles Kim
Deputy Commissioner
USPTO
Hannah Rosenfeld
Digital Health Center of Excellence, Division of Digital Health Policy (DDHP), Center for Devices and Radiological Health
U.S. Food and Drug Administration
Elham Tabassi
Associate Director for Emerging Technologies
National Institute of Standards and Technology (NIST)
Lora Spencer
Senior Global Litigation & Investigations Counsel
Medtronic
Nick Mercker
AVP, Assistant General Counsel – Chief Privacy Officer and Head of Privacy, Cyber and AI Legal
Eli Lilly and Company
Sheea Sybblis
Vice President, Human Pharma Business Law
Boehringer Ingelheim
Hans Sauer
Deputy General Counsel, VP for IP
Biotechnology Industry Organization (BIO)
Betsy Greytok
Associate General Counsel, Foundation Models
IBM Corporation
Daniel Fisher
Director, Digital & Data
Merck
Huong Nguyen
Vice President, General Counsel, & Compliance Officer
Fosun Pharma USA Inc.
Zheng Yang
Worldwide Head, AI/ML Strategy and Solutions
Healthcare and Life Sciences
Amazon Web Services
Shaping the Future of the Life Sciences: The EU AI Act’s Impact
Navigating FDA and EMA Directives for AI in Life Sciences
AI Litigation Across the Lifecycle of Life Sciences Products: From Pre-Commercialization to Post-Market Risks
AI Governance and Regulatory Sandboxes: Testing Innovation in Life Sciences
The Future of AI in the Life Sciences: Post-Election Regulatory Shifts and Strategic
IP Protections for AI-Driven Innovations: Navigating Ownership and Inventorship Challenges in the Life Sciences
Forging Strategic AI Partnerships in the Life Sciences: Building Success from Research to Implementation
Navigating Data Privacy Challenges and AI in the Life Sciences: A Global Roadmap for the Digital Age
AI in Action: Enhancing Clinical Decision-Making with AI
Life science companies will have to grapple with unique questions in complying with the European Artificial Intelligence Act, including the scope of the law’s research exemption and the use of AI in personalized medicine and real world-evidence.
Learn more about ACI’s Life Science AI Advisory Board, who counsels the ACI team on the impact of legal, regulatory, and compliance trends and emerging topics in the evolving life science arena.
A deep understanding of the legal, regulatory, compliance, and ethical concerns related to the use of AI, ML and data analytics in life sciences
Real-world case studies and examples of best practices for addressing potential challenges that come with AI
The opportunity to engage in discussions with industry thought leaders and peers from across the country to share knowledge, solutions, and ideas
An expanded professional network and valuable connections
We invite you to explore the latest breakthroughs in AI law, ethics, and life sciences through our exclusive events and workshops. Engage with top industry leaders, participate in hands-on experiences, and deepen your knowledge in AI technologies that are shaping the future.
This series offers a unique opportunity to not only learn from visionary experts but also position your firm as a leader in AI. Secure your place today and take the next step toward becoming a driving force in this rapidly evolving field.
Learn More
